PMFA
ARIA

Plante Moran Financial Advisors’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Plante Moran Financial Advisors’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-178
Closed -$3K – 688
2013
Q2 		$3K Buy
+178
New +$3.16K ﹤0.01% 516

Other funds holding ARIA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Plante Moran Financial Advisors's ARIA Position: Q3 2013 in Review

Plante Moran Financial Advisors sold out of Ariad Pharmaceuticals Inc (ARIA) in Q3 2013, closing a stake of 178 shares — an estimated $3K sold.

Plante Moran Financial Advisors first reported a position in ARIA in Q2 2013 and held it in 1 quarter. The position peaked at $3K in Q2 2013. 208 funds tracked by Wall St. Rank hold ARIA as of Q3 2013.

  • Plante Moran Financial Advisors reported no remaining Ariad Pharmaceuticals Inc position as of Q3 2013 after selling out during the quarter.
  • Plante Moran Financial Advisors sold 178 Ariad Pharmaceuticals Inc shares in Q3 2013, an estimated $3K.
  • Plante Moran Financial Advisors first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 1 quarter.
  • Plante Moran Financial Advisors's Ariad Pharmaceuticals Inc position peaked at $3K in Q2 2013.
  • 208 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q3 2013.

Based on Plante Moran Financial Advisors's 13F filing for Q3 2013, filed 23 Oct 2013.